腫瘤基因 的英文怎麼說

中文拼音 [zhǒngliúyīn]
腫瘤基因 英文
oncogene
  • : Ⅰ名詞(隆起處) swelling Ⅱ動詞(突起) swell; be swollen
  • : 名詞(瘤子) tumour
  • : Ⅰ動詞[書面語] (沿襲) follow; carry on Ⅱ介詞1 [書面語] (憑借; 根據) on the basis of; in accord...
  • 腫瘤 : tumour; core (綿羊體內的); neoplasm; phyma
  1. Comprehensive cellular responses was found in human amnion fl cells following exposure to low concentration of mnng, such as the lowering of dna replication fidelity resulted from alteration of dna polymerase profile ; activation of a lot of transcription factors, such as api, creb, nf - kb etc ; clustering of egfr ( epidermal growth factor receptor ) and tnfr ( tumor necrosis factor receptor ) and activation of camp - pka - creb and jnk / sapk signal pathways

    我們發現,低劑量mnng處理后的人羊膜fl細胞有廣泛的細胞反應,並有多個信號轉導通路的激活和表達的改變。例如dna復制保真度下降, dna聚合酶譜發生改變,應用報告技術和底物磷酸化檢出技術證明細胞一系列轉錄子如ap1 、 creb 、 nf b等被激活,細胞表面受體如表皮生長子受體、壞死子受體發生聚簇,細胞信號轉導通路camp - pka - creb和jnk sapk被激活。
  2. The b lymphocyte stim lator ( blys ) also known as baff, tall - 1, thank, ztnf4, is the most recent addition to the tumor necrosis factor family ( tnf ) ligands. blys induces both in vivo and in vitro b cell proliferation, differentiation and immunoglob lin secretion. meanwhile, it also strongly suppresses the growth of tumor cell lines. the over - production of blys is associated with the development of certain autoimmune disease, such as systemic lupus erythaematosus ( sle ), rheumatoid arthritis, myasthenia gravis, sj greh ' s syndrome

    人b淋巴細胞刺激子( hblys )是1999年發現的壞死子超家族成員。最早發現其可誘導細胞凋亡,之後發現它是一個強有力的b細胞共刺激子,它在體外及轉動物體內可明顯刺激b細胞的生長,免疫球蛋白分泌,並導致動物自身免疫性改變。
  3. Because suffer from uremia, a serious illness such as dialytic, mental disease, malignant tumor weighs ill especially tired personnel, through helping each other the side is stranded, cost of individual conceit medical treatment still has difficulty, and the cure that influence family lives basically protects a boy or girl friend, can grant appropriate allowance, deliverance of medical treatment of annual accumulative total does not exceed 5000 yuan commonly

    患尿毒癥透析、精神病、惡性等大病重病的特困人員,經過互助幫困,個人自負醫療費仍有困難,且影響家庭本生活的醫保對象,可給予適當補助,全年累計醫療救助一般不超過5000元。
  4. In addition, axud1 has a high homologue with transforming growth facotr beta ( tgf - ) induced apoptosis protein 2 and 12 using blast exploration at genebank database. these suggest that axudl may have a tumor - suppressor function in these organs and may play an important role in tgf - - induced apoptosis

    通過genkbank上blast的搜索結果表明, axud1與tgf -誘導的凋亡蛋白2 、 12 ( taip - 2 、 taip - 12有較高的同源性,提示axud1可能是一個具有抑制功能的,並可能在tgf -誘導的細胞凋亡中起著重要作用。
  5. In 2005, researchers at sloan - kettering reported that the gene could stop massie tumor growth in prostate cancer een when another tumor suppressor, known as p53, was turned off

    早在2005年,斯隆-凱特琳中心的研究人員就曾報道了在另一種叫做p53的抑制關閉時,該甚至仍然可以阻止前列腺癌大生長。
  6. Tumor necrosis factor ( tnf ), a cytkine that exerts many pro - atherosclerotic effects in vivo, causes up - regulation of acat - 1 gene expression in human blood monocytes. by luciferase activity assay, tnf - a enhanced acat - 1 p7 promoter activity in thp - 1 monocytic cell line

    細胞子tnf -即壞死子大量存在於人動脈粥樣硬化斑塊中,本實驗通過熒光素酶活性和rt - pcr測定結果表明, tnf -處理人血單核細胞和單核細胞株thp - 1均增強acat - 1p7啟動子活性。
  7. Mouse homeobox gene pem was newly isolated in 1990 ' s. its expression pattern during the murine ontogeny and in the adult tissues is unique, namely, in a stage and spatial specific manner

    Pem在小鼠發育過程及成體部分組織中呈時間和空間特異性表達,並在一系列細胞株中持續表達。
  8. Effect of rhubarb on gene expression of tumor necrosis factor in liver after scald

    大黃對燙傷后肝臟內壞死表達的影響
  9. An ethical analysis of the research and application of the human gene

    人類腫瘤基因治療的倫理問題
  10. The research by dr lam and his collaborators from university of california, san francisco and genetech, inc. which was published in nature, a world s leading scientific journal, identifies an activating mutation in the smoothened ( smo ) gene in sporadic bccs

    的科學家合作研究,發現從散發性底細胞病例中鑒定出圓滑蛋白的一種活化突變,使圓滑蛋白變成腫瘤基因,導致底細胞的出現。
  11. Preparation of carcinoembryonic antigen positive tumor gene vaccine capsules for oral use

    癌胚抗原腫瘤基因疫苗膠囊的研製
  12. Methods dna chip was used to detect the mrna from 11 human transitional cell carcinoma tissues and to investigate the genes related to signal transduction

    方法使用人腫瘤基因表達譜晶元檢測11例膀胱移行細胞癌組織表達譜的變化,以尋找與細胞信號轉導相關的差異表達
  13. Results : gene therapy for cancers in the whole world is under the stage of r & d recently, but still no drugs come into market. after zealously pursued for several years, gene therapy for cancers has gone into a stable developing stage gradually

    結果:通過專利分析發現世界腫瘤基因治療領域正處研發階段,尚無藥品正式上市,在經過狂熱期后已逐漸進入穩步發展期。
  14. Advance in research on targeting of gene therapy

    腫瘤基因治療的靶向性研究進展
  15. Classification of breast cancer genes with a simplified fuzzy artmap approach

    於模糊自適應共振網路簡化模型方法的乳腺腫瘤基因分類
  16. Biopharmaceutical industry in china has made rapid progress in the last 10 years. to date, gene therapy for cancers in china has also been studied

    近年來,我國生物制藥行業不斷發展,在腫瘤基因治療領域也取得了一定成績。
  17. Due to the features of new technologies of modem biotechnology and gene therapy for cancers, expert methods should be used to analyse the industry and related developing technologies

    由於腫瘤基因治療領域高新技術的特點決定了它需要有專門的分析方法來對其進行技術分析與預測。
  18. In this paper patent analysis is used to analyse the current status and the trends. comparative studies of china and the world in the area of gene therapy are also conducted

    本文即是將專利分析方法具體運用於分析我國腫瘤基因治療領域的現狀及發展趨勢之中,並進行國內外對比研究。
  19. Then using the technique of patent analysis and the following indicators such as patent numbers of past years, technology life circle, patent technology area, the competitive ability of facilities and so on. we analysed the patents in the area of gene therapy for cancers. swot method is also used to analyse the results from patent analysis, and then the developmental countermeasures are put forward

    方法:通過對國內外生物制藥行業發展現狀的總體分析,及針對國內外腫瘤基因治療領域運用專利歷年數量、技術生命周期、地區分佈情況、專利技術內容、機構競爭力等專利分析指標與方法來進行對比分析,將分析結果結合運用swot分析法,提出相應發展對策。
  20. By this means we can find out the hotspots and estimate the current researches and development of facilities. compared the situation about gene therapy for cancers in china with that of the whole world, the developmental countermeasures are put forward correspondingly after disadvantages of the area in china being pointed out. methods : current status of biopharmaceutical industry in china and abroad is analysed first as a whole

    目的:本課題旨在通過收集國內外腫瘤基因治療專利數據並運用專利分析指標及相應分析方法,了解國內腫瘤基因治療領域的整體現狀及技術發展趨勢,把握其研究熱點及機構研發現狀,並與國外腫瘤基因治療的發展進行對比分析,找出自身發展中存在的不足,提出相應的發展對策。
分享友人